datum (n=1)RE: https://disabled.social/@tomkindlon/116372023920930679
Related old research:
Among hospitalized COVID-19 patients, increased eBV [estimated blood viscosity] is significantly associated with higher mortality [1]
and
patients with COVID-19 had increased blood viscosity despite lower hematocrit than healthy individuals, as well as increased RBC aggregation. In-vitro experiments demonstrated a strong contribution of plasma fibrinogen in this RBC hyper-aggregation. RBC aggregation correlated positively with clot firmness, negatively with clot formation time, and positively with the length of hospitalization. [2]
[1] https://doi.org/10.1016/j.jacc.2022.04.060
[2] https://doi.org/10.1002/ajh.26440